MedPath

Prevention of TaT1 bladder cancer by BCG instillation: Induction alone versus induction and maintenance

Not Applicable
Recruiting
Conditions
bladder cancer
Registration Number
JPRN-UMIN000009508
Lead Sponsor
Department of Urology and Andrology, Kansai Medical university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
160
Inclusion Criteria

Not provided

Exclusion Criteria

1) first diagnosed Ta bladder cancer, and solitary, and less than 1cm, and urine cytology negative, and with CIS (carcinoma in situ) 2) past history of BCG instillation 3)1) error correction Urine cytology positive after TUR-Bt is excluded. pTa and solitary is excluded. With CIS is excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Progression free survival, (time to progression)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath